Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Clinical trial NCT06419634 · RECRUITING
Trial details
- NCT number
- NCT06419634
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-29
- Primary completion
- 2027-02-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.